Group 1 - The core viewpoint of the news is that New Mile Health Technology Group Co., Ltd. has experienced fluctuations in stock price and financial performance, with a notable decline in revenue and net profit for the year 2025 [1][2]. Group 2 - As of January 5, New Mile's stock price increased by 2.35% to 2.18 CNY per share, with a total market capitalization of 7.384 billion CNY [1]. - The company reported a revenue of 2.256 billion CNY for the period from January to September 2025, representing a year-on-year decrease of 15.84% [2]. - The company's main business revenue composition includes 86.79% from medical services and 13.12% from pharmaceuticals and medical products [1]. - New Mile has not distributed any dividends in the past three years, with a total payout of 70.3476 million CNY since its A-share listing [3]. - As of December 20, the number of shareholders decreased to 68,400, while the average circulating shares per person increased by 1.30% to 47,850 shares [2].
新里程涨2.35%,成交额7166.80万元,主力资金净流出468.41万元